Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16…
69% surge in entrepreneurs signals new era of growth
LinkedIn’s latest research reveals small businesses are entering 2026 with confidenceAuthenticity and…
Fenova uPVC Door & Window Systems Recognized by Forbes India DGEMS as a SELECT 200 Company with Global Business Potential
SOLAPUR, India, Dec. 3, 2025 /PRNewswire/ -- Fenova uPVC Door & Window…
The Global Power of Sport: Bank of America Partners with Great Ethiopian Run to Expand Access to Endurance Sports
Beginning in 2026, Partnership Will Elevate Flagship Race's Global Profile and Significantly…
OMD NAMED BEST PERFORMING GLOBAL MEDIA NETWORK FOR THE TENTH CONSECUTIVE TIME
New RECMA Diagnostics Report Reveals OMD "Remains More than Ever the Leader"…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET Â | Source: C4 Therapeutics, Inc. Cemsidomide in…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
Former Google Exec Outlines the High-Stakes Battle Behind Google Reviews on Maury Blackman’s Great Minds Think Data
Brad Wetherall, former Director for Google Business Profile, details survival tactics for…
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ --Â A recently published five-year pharmacovigilance study confirms…
Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISAâ„¢ technology. FREMONT,…